Skip to main content
Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
15.13
-0.68 (-4.30%)
At close: Nov 13, 2026, 4:00 PM EST
15.22
+0.08 (0.56%)
After-hours: Nov 13, 2026, 4:10 PM EST

Attovia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Market Capitalization
691--
Market Cap Growth
---
Enterprise Value
299--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.010.04-
Net Debt / Equity Ratio
-0.99-0.97-1.12
Net Debt / EBITDA Ratio
4.632.221.68
Net Debt / FCF Ratio
5.002.391.88
Asset Turnover
-0.01-
Quick Ratio
33.9213.928.99
Current Ratio
34.6614.209.39
Return on Equity (ROE)
--56.95%-
Return on Assets (ROA)
--34.60%-
Return on Capital Employed (ROCE)
-21.40%-43.40%-60.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Buyback Yield / Dilution
-198.23%-11.84%-
SEC Filings: 10-K · 10-Q